A Study of a Rilpivirine Extended-Release Suspension in Healthy Participants
Status:
Not yet recruiting
Trial end date:
2023-08-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the single dose pharmacokinetics (PK) and
evaluate the safety and tolerability of subcutaneous administration of rilpivirine (RPV)
long-acting (LA) extended release suspensions in different conditions in healthy adult
participants.